Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 49.04B | 49.82B | 42.11B | 42.72B | 43.09B | 46.44B |
Gross Profit | 11.29B | 11.62B | 7.35B | 7.81B | 8.67B | 7.94B |
EBITDA | 6.99B | 7.58B | 4.48B | 6.35B | 7.26B | 5.74B |
Net Income | 3.66B | 3.97B | 1.64B | 2.86B | 3.91B | 2.16B |
Balance Sheet | ||||||
Total Assets | 71.26B | 71.74B | 68.82B | 67.66B | 68.69B | 67.26B |
Cash, Cash Equivalents and Short-Term Investments | 16.52B | 16.96B | 18.16B | 20.65B | 18.38B | 14.46B |
Total Debt | 10.30B | 10.23B | 10.89B | 10.24B | 9.09B | 8.22B |
Total Liabilities | 24.57B | 23.18B | 22.57B | 20.55B | 20.72B | 19.81B |
Stockholders Equity | 46.69B | 48.56B | 46.25B | 47.11B | 47.94B | 46.48B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.34B | -559.77M | -904.26M | 3.89B | -1.37B |
Operating Cash Flow | 0.00 | 4.55B | 3.22B | 3.47B | 5.90B | 610.51M |
Investing Cash Flow | 0.00 | -2.08B | -1.06B | 508.63M | 2.87B | 1.57B |
Financing Cash Flow | 0.00 | -4.09B | -3.42B | -2.57B | -4.04B | -5.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥56.24B | 12.10 | 4.03% | -3.25% | -35.91% | ||
79 Outperform | ¥47.69B | 12.03 | 5.84% | 18.29% | 141.54% | ||
79 Outperform | ¥47.08B | 12.96 | 2.45% | 2.05% | 46.96% | ||
78 Outperform | ¥36.10B | 5.98 | 2.32% | 2.37% | 11.78% | ||
76 Outperform | ¥63.74B | 24.00 | 0.92% | 20.24% | 33.60% | ||
73 Outperform | ¥48.92B | 8.01 | 2.12% | 8.28% | 22.23% | ||
63 Neutral | $33.76B | 6.14 | -11.84% | 1.84% | 5.29% | -18.23% |